Home » Newsletters » BioWorld Science

BioWorld Science

May 31, 2017

View Archived Issues

ZFPM2 found as a gene for primary ovarian insufficiency

Pfizer announces European approval of the Meningococcal Group B vaccine Trumenba

VesiGel shows promise as alternative to resection in nonmuscle-invasive bladder cancer

Nippon Boehringer Ingelheim and Kobe University enter diabetes agreement

FDA clears IND for LOXO-195

Novel bile acid receptor agonist BAR-704 limits experimental liver fibrosis

Four phase III studies of bictegravir/emtricitabine/tenofovir alafenamide meet primary endpoints

Sanofi and ImmunoGen amend cancer immunotherapy agreements

University of Michigan begins phase I trial of oral heptapeptide KSP-910638G

Inspyr Therapeutics to merge with Lewis and Clark Pharmaceuticals to create novel integrated company

Asana BioSciences advances phase I/II study of ASN-002

i2 Pharmaceuticals acquires antibody and protein therapeutics portfolio

BAMBI inhibition is beneficial in autoimmune diseases

C1orf198 found to be a predictor of metastasis in bladder cancer

Wockhardt discloses compounds for treating bacterial infections

Daewoong Pharmaceutical presents Nav1.7 channel blockers

TD-139 well tolerated and affects biomarkers in idiopathic pulmonary fibrosis trial

AstraZeneca identifies MAPK1 inhibitors

Eisai presents AMPA receptor antagonists

Fennec launches European Named Patient Program for sodium thiosulfate

Zhejiang Hisun Pharmaceutical divulges estrogen receptor alpha modulators

FDA gives rare pediatric disease designation to EB-101 from Abeona

Ligand Pharmaceuticals enters agreement with xCella Biosciences

Phase III RANGE urothelial cancer study of ramucirumab meets primary endpoint

Array and Ono partner to develop and commercialize binimetinib and encorafenib

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...